Evidence-Based GI: An ACG Publication and Podcast

By American College of Gastroenterology

Each month the Editors-in-Chief Dr. Philip Schoenfeld interviews Associate Editors who review recently published articles related to the field of GI published in non-GI journals. A must-listen for an... more

4.7

1717 ratings

FAQs about Evidence-Based GI: An ACG Publication and Podcast:

How many episodes does Evidence-Based GI: An ACG Publication and Podcast have?

The podcast currently has 146 episodes available.

Best of Evidence-Based GI: An ACG Publication and Podcast

The most played episodes among Podcast App listeners.

Number 1: IBD surveillance colonoscopy: to spray or not to spray!
Vasantham Chaudhary, MD and Elie Al Kazzi, MD, MPH discuss "Surveillance in inflammatory bowel disease: white light endoscopy with segmental re-inspection versus dye-based chromoendoscopy – a multi-arm randomised controlled trial (HELIOS)," by Te Groen M, Wijnands AM, den Broeder N, et al. Published in Gut 2025;75:547-556.
May 21, 202512min
Number 2: Increased ATTENTION to Early Initiation of Antiviral Therapies in Chronic Hepatitis B Based on Viral Load
Leandro Sierra, MD and Joseph Lim, MD discuss "Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial,” by Lim Y. S., Yu M. L., Choi J., et al. Published in Lancet Gastroenterol Hepatol 2025; 10(4):295-305.
May 15, 202513min
Number 3: Risankizumab is Superior to Placebo for Induction and Maintenance of Moderate-Severe Ulcerative Colitis (UC): Assessing the UC Treatment Paradigm
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Rahul Dalal, MD, MPH discuss “Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials,” by Louis E, Schreiber S, Panaccione R, Bossuyt P, et al for the INSPIRE and COMMAND Study Group. JAMA. 2024 Jul 22:e2412414
September 18, 202417min
Number 4: Risankizumab is Superior to Ustekinumab for Induction and Maintenance of Crohn’s disease: The SEQUENCE Trial
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Bharati Kochar, MD, MS discuss “Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease,” by Peyrin-Biroulet L, Chapman JC, Colombel JF, et al. N Engl J Med 2024;391:213-223.
August 21, 202422min
Number 5: ICYMI: ACG Clinical Guideline on Gastroparesis-Limited Evidence-Based Options
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Elie Al Kazzi, MD, MPH discuss “ACG Clinical Guideline: Gastroparesis,” by Camilleri M, Kuo B, Nguyen L, et al. Am J Gastroenterol 2022;117(8):1197-1220.
August 21, 202421min